Dopamine agonists and hyperprolactinaemia

BMJ. 2009 Mar 3:338:b381. doi: 10.1136/bmj.b381.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bromocriptine / adverse effects*
  • Cabergoline
  • Dopamine Agonists / adverse effects*
  • Ergolines / adverse effects*
  • Heart Valve Diseases / chemically induced*
  • Humans
  • Hyperprolactinemia / drug therapy*

Substances

  • Dopamine Agonists
  • Ergolines
  • Bromocriptine
  • Cabergoline